Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Reimbursement Reforms: Manufacturers Torn, Physicians Defiant

This article was originally published in The Gray Sheet

Executive Summary

The impending launch of a system resembling diagnosis-related groups (DRGs) in Japan could give the Ministry of Health, Labor and Welfare the upper hand in future payment negotiations with U.S. firms

You may also be interested in...



Japan Device Pricing To Benefit From Hospital Efficiency Incentives

The Ministry of Health, Labor & Welfare in Japan will offer hospitals a 15% bonus payment for reducing the time patients remain in the inpatient setting, provided the centers fall within the top length-of-stay quartile

Japan Device Pricing To Benefit From Hospital Efficiency Incentives

The Ministry of Health, Labor & Welfare in Japan will offer hospitals a 15% bonus payment for reducing the time patients remain in the inpatient setting, provided the centers fall within the top length-of-stay quartile

Japan Reforms Failed To Sate U.S. Firms In 2002; EU Reuse Drive Ebbs, Wanes

AdvaMed will capitalize on new Exec. VP-Global Strategy & Analysis Marjory Searing's rapport with Japan Ministry of Health, Labor & Welfare officials to renew its assault on foreign reference pricing in 2003

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel